WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin Charles GormanDirector2025-05-279,613$120.38
$1.16MSell
Julie CookeChief Human Resources Officer2025-05-166,468$61.82
$399.85kBuy
William H. RastetterDirector2025-05-0530,000$110.20
$3.31MSell
William H. RastetterDirector2025-05-0530,000$42.76
$1.28MBuy
Eiry RobertsChief Medical Officer2025-02-14500$115.04
$57.52kSell
Matt AbernethyChief Financial Officer2025-02-131,352$116.85
$157.98kSell
Matt AbernethyChief Financial Officer2025-02-131,206$116.87
$140.94kSell
Kyle GanoChief Executive Officer2025-02-131,352$116.85
$157.97kSell
Stephen A. SherwinDirector2025-02-1313,831$116.69
$1.61MSell
Eric BenevichChief Commercial Officer2025-02-131,098$116.74
$128.18kSell

1 of 10

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P35.42%35,058,600$4.36BInsider
Blackrock Inc14.84%14,682,394$1.83BInstitution
Vanguard Group Inc10.05%9,941,887$1.24BInstitution
Dodge Cox5.59%5,534,624$688.45MInstitution
State Street Corp4.91%4,862,116$604.80MInstitution
Jpmorgan Chase Co2.70%2,670,998$332.25MInstitution
Renaissance Technologies LLC2.53%2,502,697$311.31MInstitution
Wellington Management Group LLP2.12%2,097,981$260.97MInstitution
Geode Capital Management LLC1.99%1,969,754$245.02MInstitution
Bellevue Group Ag1.84%1,820,000$226.39MInstitution

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX70.14%29.86%Net SellingNet Selling
RDY13.12%0.00%
VTRS81.63%18.14%Net SellingNet Buying
RGC0.07%0.00%
ELAN90.57%9.43%Net SellingNet Selling
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 95.08% institutional shareholders, 40.49% Neurocrine Biosciences insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 35.42% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $4.36B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.